Study S002356

A Single-Center, Open-Label Study to Evaluate the Effect of XW003 Injection on the Pharmacokinetics of Metformin, Warfarin, Rosuvastatin or Digoxin in Healthy Subjects

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06335134
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 57
Start: 2023-07-14
Primary completion: 2024-01-08
Lead sponsor: Hangzhou Sciwind Biosciences Co., Ltd.
Conditions: Healthy Volunteers
Interventions: DRUG:XW003 injection; DRUG:Metformin; DRUG:Warfarin; DRUG:Rosuvastatin; DRUG:Digoxin
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Pharmacokinetics of metformin: AUC0-inf [up to 101 days]
Pharmacokinetics of S-warfarin and R-warfarin: AUC0-inf [up to 114 days]
Pharmacokinetics of rosuvastatin: AUC0-inf [up to 102 days]
Pharmacokinetics of digoxin: AUC0-inf [up to 112days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.